Brief: Artelo Biosciences Announces Positive First-In-Human Data For ART26.12, A Novel Non-Opioid Treatment Candidate For Persistent Pain
30/06/2025 12:48
June 30 (Reuters) - Artelo Biosciences Inc ARTL.O: ARTELO BIOSCIENCES ANNOUNCES POSITIVE FIRST-IN-HUMAN DATA FOR ART26.12, A NOVEL NON-OPIOID TREATMENT CANDIDATE FOR PERSISTENT PAIN ARTELO BIOSCIENCES INC - ALL ADVERSE EVENTS WERE MILD, TRANSIENT, AND SELF-RESOLVING ARTELO BIOSCIENCES INC - PLASMA ANALYSIS CONFIRMED DOSE-DEPENDENT, LINEAR ABSORPTION Source text: ID:nGNX462pbn Further company coverage: ARTL.O ((Reuters.Briefs@thomsonreuters.com;))